UBS Group’s Algorhythm Holdings RIME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.2K Buy
66,250
+65,760
+13,420% +$89.1K ﹤0.01% 7165
2025
Q4
$495 Buy
490
+462
+1,650% +$862 ﹤0.01% 9935
2025
Q3
$74 Sell
28
-19,002
-100% -$44.2K ﹤0.01% 9973
2025
Q2
$46.6K Sell
19,030
-21,455
-53% -$54.8K ﹤0.01% 7828
2025
Q1
$87K Buy
+40,485
New +$271K ﹤0.01% 7150
2024
Q2
Sell
-3
Closed -$512 10238
2024
Q1
$512 Buy
3
+2
+200% +$356 ﹤0.01% 8509
2023
Q4
$143 Buy
+1
New +$197 ﹤0.01% 8873
2023
Q3
Sell
-1
Closed -$133 10058
2023
Q2
$133 Sell
1
-12
-92% -$3.39K ﹤0.01% 8461
2023
Q1
$4.09K Sell
13
-6
-32% -$4.16K ﹤0.01% 8236
2022
Q4
$16.6K Buy
19
+15
+375% +$15.9K ﹤0.01% 7893
2022
Q3
$4K Sell
4
-10
-71% -$15.3K ﹤0.01% 9411
2022
Q2
$22K Buy
+14
New +$15.5K ﹤0.01% 6779

Other funds holding RIME

UBS Group's RIME Position: Q1 2026 in Review

UBS Group increased its Algorhythm Holdings (RIME) stake by 13,420% in Q1 2026, buying an estimated $89.1K and bringing the position to 66,250 shares worth $72.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7165.

UBS Group first reported a position in RIME in Q2 2022 and has held it in 12 quarters since. The position peaked at $87K in Q1 2025. 24 funds tracked by Wall St. Rank hold RIME as of Q1 2026.

  • UBS Group held 66,250 shares of Algorhythm Holdings worth $72.2K as of Q1 2026.
  • UBS Group bought 65,760 Algorhythm Holdings shares in Q1 2026, an estimated $89.1K.
  • Algorhythm Holdings made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7165 holding.
  • UBS Group first reported a position in Algorhythm Holdings in Q2 2022 and has held it in 12 quarters since.
  • UBS Group's Algorhythm Holdings position peaked at $87K in Q1 2025.
  • 24 funds tracked by Wall St. Rank held Algorhythm Holdings as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.